174 related articles for article (PubMed ID: 28862245)
1. Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult.
Devine MF; Herrin C; Warnack W; Dubey D
J Postgrad Med; 2018; 64(1):53-55. PubMed ID: 28862245
[TBL] [Abstract][Full Text] [Related]
2. Controlled-release carbidopa/levodopa in the treatment of Parkinsonism.
Hutton JT; Dippel RL; Bianchine JR; Strahlendorf HK; Meyer PG
Clin Neuropharmacol; 1984; 7(2):135-9. PubMed ID: 6375861
[TBL] [Abstract][Full Text] [Related]
3. Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence.
Stagg P; Grice T
Anaesth Intensive Care; 2011 Nov; 39(6):1128-30. PubMed ID: 22165370
[TBL] [Abstract][Full Text] [Related]
4. 24 h Levodopa-carbidopa intestinal gel may reduce falls and "unresponsive" freezing of gait in Parkinson's disease.
Chang FC; Tsui DS; Mahant N; Wolfe N; Kim SD; Ha AD; Drury M; Griffith JM; Fung VS
Parkinsonism Relat Disord; 2015 Mar; 21(3):317-20. PubMed ID: 25578290
[TBL] [Abstract][Full Text] [Related]
5. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
[TBL] [Abstract][Full Text] [Related]
6. Use of carbidopa-levodopa in a patient with hydrocephalus and frozen movement.
Aggarwal S; Childers MK; Jimenez D
Brain Inj; 1997 Nov; 11(11):831-6. PubMed ID: 9354260
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
Sundal C; Fujioka S; Van Gerpen JA; Wider C; Nicholson AM; Baker M; Shuster EA; Aasly J; Spina S; Ghetti B; Roeber S; Garbern J; Tselis A; Swerdlow RH; Miller BB; Borjesson-Hanson A; Uitti RJ; Ross OA; Stoessl AJ; Rademakers R; Josephs KA; Dickson DW; Broderick D; Wszolek ZK
Parkinsonism Relat Disord; 2013 Oct; 19(10):869-77. PubMed ID: 23787135
[TBL] [Abstract][Full Text] [Related]
8. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
Savery F
Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.
Müller T; Ander L; Kolf K; Woitalla D; Muhlack S
J Neural Transm (Vienna); 2007; 114(11):1457-62. PubMed ID: 17564755
[TBL] [Abstract][Full Text] [Related]
10. Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with "on" freezing of gait.
Cossu G; Ricchi V; Pilleri M; Mancini F; Murgia D; Ricchieri G; Mereu A; Melis M; Antonini A
Neurol Sci; 2015 Sep; 36(9):1683-6. PubMed ID: 25939726
[TBL] [Abstract][Full Text] [Related]
11. Freezing of Gait in Parkinsonism and its Potential Drug Treatment.
Zhang LL; Canning SD; Wang XP
Curr Neuropharmacol; 2016; 14(4):302-6. PubMed ID: 26635194
[TBL] [Abstract][Full Text] [Related]
12. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa.
Aarli JA; Gilhus NE
Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767
[TBL] [Abstract][Full Text] [Related]
13. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
Ondo WG; Shinawi L; Moore S
Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
Wakusawa K; Haginoya K; Kitamura T; Togashi N; Ishitobi M; Yokoyama H; Higano S; Onuma A; Nara T; Iinuma K
Tohoku J Exp Med; 2006 Jun; 209(2):163-7. PubMed ID: 16707859
[TBL] [Abstract][Full Text] [Related]
15. Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease.
Zibetti M; Angrisano S; Dematteis F; Artusi CA; Romagnolo A; Merola A; Lopiano L
J Neurol Sci; 2018 Feb; 385():105-108. PubMed ID: 29406886
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
17. Sinemet CR in Parkinson's disease.
Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R
Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
[TBL] [Abstract][Full Text] [Related]
18. Successful Utilization of Levodopa in HIV-Induced Parkinsonism.
Almajali M; Almajali F; Kafaie J; Chand P
Cureus; 2020 Dec; 12(12):e11825. PubMed ID: 33409067
[TBL] [Abstract][Full Text] [Related]
19. Update on drug treatment of Parkinsonism.
Winkelman AC
Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001
[No Abstract] [Full Text] [Related]
20. An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients.
Olanow CW; Nakano K; Nausieda P; Tetrud JA; Manyam B; Last B; Block G; Liss C; Bush D
Clin Neuropharmacol; 1991 Jun; 14(3):235-40. PubMed ID: 2070363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
